ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Delcath Systems Inc

Delcath Systems Inc (DCTH)

15.34
-0.30
(-1.92%)
15.83
0.49
(3.19%)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
15.83
Bid
15.08
Ask
15.80
Volume
316,419
15.12 Day's Range 15.57
7.1173 52 Week Range 18.23
Market Cap
Previous Close
15.64
Open
15.30
Last Trade
5
@
15.64
Last Trade Time
Financial Volume
$ 4,853,157
VWAP
15.3378
Average Volume (3m)
487,186
Shares Outstanding
34,826,183
Dividend Yield
-
PE Ratio
-20.25
Earnings Per Share (EPS)
-0.76
Revenue
37.21M
Net Profit
-26.39M

About Delcath Systems Inc

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy... Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Delcath Systems Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker DCTH. The last closing price for Delcath Systems was $15.64. Over the last year, Delcath Systems shares have traded in a share price range of $ 7.1173 to $ 18.23.

Delcath Systems currently has 34,826,183 shares outstanding. The market capitalization of Delcath Systems is $544.68 million. Delcath Systems has a price to earnings ratio (PE ratio) of -20.25.

DCTH Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.11-6.5525383707216.9417.35215.0846420716.0124936CS
4-0.23-1.4321295143216.0618.2315.0852403516.54698828CS
121.825513.03509586214.004518.239.7848718614.078341CS
264.0634.494477485111.7718.239.7845102613.90599433CS
528.67121.0893854757.1618.237.117338271212.08196099CS
15611.82294.7630922694.0118.232.253951247.36802151CS
2607.95100.8883248737.8825.182.252714218.05843577CS

DCTH - Frequently Asked Questions (FAQ)

What is the current Delcath Systems share price?
The current share price of Delcath Systems is $ 15.83
How many Delcath Systems shares are in issue?
Delcath Systems has 34,826,183 shares in issue
What is the market cap of Delcath Systems?
The market capitalisation of Delcath Systems is USD 544.68M
What is the 1 year trading range for Delcath Systems share price?
Delcath Systems has traded in the range of $ 7.1173 to $ 18.23 during the past year
What is the PE ratio of Delcath Systems?
The price to earnings ratio of Delcath Systems is -20.25
What is the cash to sales ratio of Delcath Systems?
The cash to sales ratio of Delcath Systems is 14.36
What is the reporting currency for Delcath Systems?
Delcath Systems reports financial results in USD
What is the latest annual turnover for Delcath Systems?
The latest annual turnover of Delcath Systems is USD 37.21M
What is the latest annual profit for Delcath Systems?
The latest annual profit of Delcath Systems is USD -26.39M
What is the registered address of Delcath Systems?
The registered address for Delcath Systems is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Delcath Systems website address?
The website address for Delcath Systems is www.delcath.com
Which industry sector does Delcath Systems operate in?
Delcath Systems operates in the SURGICAL,MED INSTR,APPARATUS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RBNERobin Energy Ltd
$ 13.85
(313.43%)
101.81M
OPOceanPal Inc
$ 1.63
(125.45%)
80.28M
LGHLWLion Group Holding Ltd
$ 0.0052
(116.67%)
6.87M
NEONNeonode Inc
$ 16.83
(68.47%)
4.78M
ICONIcon Energy Corporation
$ 2.90
(62.01%)
59.04M
SBETSharpLink Gaming Inc
$ 9.2275
(-71.63%)
41.92M
AIHSSenmiao Technology Ltd
$ 0.381
(-63.01%)
16.8M
CHSNChanson International Holding
$ 0.22
(-60.00%)
15.15M
KWMK Wave Media Ltd
$ 2.91
(-50.43%)
2.59M
JZXNJiuzi Holdings Inc
$ 1.56
(-46.39%)
2.24M
HCTIHealthcare Triangle Inc
$ 0.0201
(-33.00%)
856.89M
GNLNGreenlane Holdings Inc
$ 0.0101
(-34.42%)
792.34M
CGBSCrown LNG Holdings Ltd
$ 0.1104
(31.43%)
788.42M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 12.655
(3.81%)
246.13M
NVDANVIDIA Corporation
$ 141.97
(-2.09%)
180.81M

DCTH Discussion

View Posts
Filterthenoise Filterthenoise 1 month ago
Here we go again 🔥
👍️0
Filterthenoise Filterthenoise 3 months ago
Just me? LFG!!
👍️0
Filterthenoise Filterthenoise 12 months ago
Straight 🔥 $DCTH
👍️0
Monksdream Monksdream 12 months ago
DCTH under $10
👍️0
Filterthenoise Filterthenoise 1 year ago
$DCTH strong
👍️0
Monksdream Monksdream 1 year ago
DCTH 10Q due 3/26
👍️0
Filterthenoise Filterthenoise 1 year ago
$DCTH
👍️0
Filterthenoise Filterthenoise 2 years ago
Lets go $DCTH
👍️0
green maschine green maschine 2 years ago
6 now. That was quick.
👍️0
TheFinalCD TheFinalCD 2 years ago
5.80 HI :0)
👍️0
green maschine green maschine 2 years ago
The 5 analysts offering 12-month price forecasts for Delcath Systems Inc have a median target of 18.00, with a high estimate of 22.00 and a low estimate of 13.00. The median estimate represents a +216.62% increase from the last price of 5.69.
👍️0
dande1990 dande1990 2 years ago
H.C. Wainwright Reaffirms Their Buy Rating on Delcath Systems (DCTH)

TipRanks

 Aug. 15, 2023, 09:35 AM

In a report released today, Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on Delcath Systems (DCTH – Research Report), with a price target of $18.00. The company’s shares opened today at $5.84.
👍️0
dande1990 dande1990 2 years ago
HC Wainwright & Co. Maintains Delcath Systems (DCTH) Buy Recommendation

Story by George Maybach • 14h

?

Fintel reports that on August 15, 2023, HC Wainwright & Co. maintained coverage of Delcath Systems (NASDAQ:DCTH) with a Buy recommendation.
Analyst Price Forecast Suggests 436.15% Upside
As of August 2, 2023, the average one-year price target for Delcath Systems is 16.73. The forecasts range from a low of 10.10 to a high of $23.10. The average price target represents an increase of 436.15% from its latest reported closing price of 3.12.

👍️0
TheFinalCD TheFinalCD 2 years ago
5.13 LO :/


SO FAR
👍️0
green maschine green maschine 2 years ago
Hope you get that back working soon. I use TD Ameritrade and so far haven't had any problems with their system.
👍️0
dande1990 dande1990 2 years ago
No... On my app and my laptop I have a message saying they are unable to at the moment

$DCTH
👍️0
green maschine green maschine 2 years ago
Wow, bummer. Did they say why?
👍️0
dande1990 dande1990 2 years ago
Fidelity is down. Cant make trades at all.

$DCTH
👍️0
green maschine green maschine 2 years ago
Awesome! I need to get my correct my sleeping habits - kicking myself today.
👍️0
dande1990 dande1990 2 years ago
Ive been able to do 5.01 to 5.77 and 5.55 to 7.25. In again at 6.33.
👍️0
green maschine green maschine 2 years ago
Nice move CD. Still climbing. $$DCTH$$
👍️0
green maschine green maschine 2 years ago
I'm in at 5.43, went back to bed and missed the flip today. Oh well might see 10 by EOW.
👍️0
dande1990 dande1990 2 years ago
This board needs some life!! Lets go $DCTH
👍️0
TheFinalCD TheFinalCD 2 years ago
round ii

filled as low as 6.46 on that DIP

$DCTH
👍️0
TheFinalCD TheFinalCD 2 years ago
$7!!!!!!!!!!!!!!


SOLD SOME 6.95 AFTER 7 COULDNT BREAK HARD
👍️0
TheFinalCD TheFinalCD 2 years ago
6.70 LG!!!!!!
👍️0
SriMaharaj SriMaharaj 2 years ago
Told you guys. Get in now before it's too late.
👍️0
SriMaharaj SriMaharaj 2 years ago
Wait until it cross $6. You will see $10 today or tomorrow.
👍️0
TheFinalCD TheFinalCD 2 years ago
6.50 WAS A NICE POP OFF MY 5.55 ENTRY
👍️0
green maschine green maschine 2 years ago
Yeah there's resistance at that level, but I believe it'll break through today. Too much buying pressure here. FDA approval is huge news.
👍️0
Filterthenoise Filterthenoise 2 years ago
BOOM $DCTH
👍️0
TheFinalCD TheFinalCD 2 years ago
6.24 SO FAR BUT THEY QUICKLY SOLD IT OFF TO 5.34

DCTH
👍️0
Monksdream Monksdream 2 years ago
Early Barchart Top 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
green maschine green maschine 2 years ago
Good morning. I wonder how high this flies today.
👍️0
TheFinalCD TheFinalCD 2 years ago
https://finviz.com/quote.ashx?t=DCTH&p=d

$DCTH 🚨 Approved

Finally after years of try.

Delcath Systems, Inc. Announces FDA Approval of HEPZATO KIT™ for the Treatment of Adult Patients with Unresectable Hepatic-Dominant Metastatic Uveal Melanoma. pic.twitter.com/ZCBQZXbgzE— Ripster (@ripster47) August 15, 2023
👍️0
green maschine green maschine 2 years ago
Where is everybody?
👍️0
Carlito78 Carlito78 2 years ago
What ever happened to SamnotSamuel?
👍️0
harvest1 harvest1 2 years ago
Wow stock is down 2 weeks before PDUFA date. Hard to imagine this wont be approved this time with no adcom. Not sure why there arent more buyers. Hopefully there is a pop on approval and they have a quick launch and revenue ramp.
👍️0
Filterthenoise Filterthenoise 2 years ago
Finally! Go $DCTH
👍️0
Jmma Jmma 2 years ago
Finally looks promising for real. Had shares few years ago and got chewed up and spit out . Reverse splits wiped out a lot of investors. Looks like they turned the corner and could become the investment everyone hoped for awhile back. Good luck to those holding.
👍️0
Filterthenoise Filterthenoise 2 years ago
No one loving the start of the run?
👍️0
Filterthenoise Filterthenoise 2 years ago
Next leg time LFG $DCTH!!
👍️0
Filterthenoise Filterthenoise 3 years ago
$DCTH... LFG!
👍️0
Filterthenoise Filterthenoise 3 years ago
Let's GO!

$DCTH
👍️0
Filterthenoise Filterthenoise 3 years ago
Another run at it coming

GLTA
👍️0
harvest1 harvest1 3 years ago
A new corporate presentation was posted to the company's website with alot of updated information.
https://delcath.com/investors/events-presentations/

This company has been left for dead by the market but I think the stock could recover strongly next year after approval if revenues begin to roll in. I would be interested to hear others thoughts on catalysts and stock price targets. I think at least a $100 million market cap should be expected on approval. Longer term at least $250 million market cap when revenues are material. Starting 3 new trials in 2023 will be positive as well. There appears to be little interest or attention for the company now but hopefully that changes after approval. My biggest fear is that they will have to dilute more at these awful rock bottom prices.
👍️0
Filterthenoise Filterthenoise 3 years ago
Here we go...
👍️0
nealhugh nealhugh 3 years ago
just waiting.........................................................................
👍️0
nealhugh nealhugh 3 years ago
yup--- good chat with GA... TY. Neal
👍️0
nealhugh nealhugh 3 years ago
FDA submission Summer/Fall 2022
FDA approval possible within 6 mos of submission

Fund raise? when?

Stock price lousy so wait for the fund raise?

All results on trials and use are good!

TY, Neal
👍️0

Your Recent History

Delayed Upgrade Clock